Researchers finally quantified the hair loss risk that GLP-1 drug users have been reporting for two years, and found it is 37 to 68 percent higher than on comparable medications
GLP-1 receptor agonists have become some of the most prescribed medications in the world in a remarkably short period. Ozempic and Wegovy,…